13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Behavioral Neuroscience and Social Neuroscience
Behavioral neuroscience and social neuroscience delve into how neural processes govern individual and group behaviors, with a focus on understanding the brain's role in both personal actions and social dynamics. Behavioral neuroscience investigates how different brain regions and neural pathways control behaviors, including motor functions, decision-making, and emotional regulation. In parallel, social neuroscience looks at how interactions with others, including social cognition, empathy, and group behavior, are shaped by brain activity. This field emphasizes the study of how the brain processes social information, including facial expressions and non-verbal cues, which are critical for understanding social dynamics. Advances in both disciplines are providing insights into a range of psychological and social disorders, with implications for improving mental health treatments and promoting social well-being.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States